Philips Respironics and Brightree Team Up to Improve HME Workflow Efficiency and Patient Sleep Therapy Compliance
Integration of management solutions will enable better monitoring of patient treatment and compliance, improving care and reducing costs
October 10, 2014 – Philips Respironics , a division of Royal Philips (NYSE: PHG AEX: PHIA) and a global leader in the sleep and respiratory markets, announced the signing of an agreement withBrightree®, the leading provider of cloud-based clinical, business management and billing software solutions for the post-acute care industry, to integrate data from Philips’ EncoreAnywhere platform with Brightree’s web-based billing and business management platform. This data interoperability agreement will enable joint customers to better track and manage therapy compliance of sleep-disordered breathing patients and is part of Philips’ ongoing commitment to develop end-to-end sleep solutions across the entire continuum of care – from prevention to diagnosis and treatment through wellness.
“Philips Respironics is the only company in the industry to offer solutions that touch every part of a patient’s care journey, uniquely positioning us to help our home medical equipment customers better manage patient care on an ongoing basis,” said John Frank, senior vice president and general manager of Philips Respironics. “With the integration with Brightree, Philips is creating a highly-automated and secure platform for HMEs that can offer significant efficiency gains, but most importantly, improve patient care through more streamlined therapy compliance business processes.”
Philips’ collaboration with Brightree is an integral part of The Answer, a three-phased process that enables HMEs to seamlessly connect Philips’ product, technology and workflow innovations to transform their businesses. This integration with Brightree enables HME customers to eliminate time spent on manual and duplicate data entry tasks associated with monitoring compliance that can lead to inconsistent data and staff inefficiencies and allows the HME to focus on the needs of their patients.
EncoreAnywhere from Philips Respironics is the most widely used web-based patient-compliance management system in the US with over 5.4 million active patients and over 60,000 clinical users. It makes treating patients with sleep disorders easier and more efficient through its unique patient compliance management capabilities, including comprehensive tracking and reporting tools for the overall treatment progress of patient populations for both HMEs and clinicians.
The integration of Brightree’s HME billing and business management platform with Philips EncoreAnywhere automates the patient data entry process, improving the HME’s staff efficiency and accuracy of entering and tracking their patients’ sleep therapy compliance. The integration is bidirectional, meaning Brightree will share and allow for patient registration and demographic information to be populated into EncoreAnywhere, and compliance and therapy adherence reports generated by Philips software will be shared and viewable in Brightree solutions, eliminating the need for duplicate data entry. HME customers will be able to deliver a higher level of connected care with more accuracy in less time, which will help reduce costs and improve patient compliance.
Philips and Brightree share a common vision for providing solutions that aim to help providers keep patients healthy as effectively and efficiently as possible. To show how this vision is coming to life, both Philips and Brightree will have previews of this new integration in their respective booths, Philips #1711 and Brightree #2245 at the upcoming Medtrade Fall conference, October 21-23, 2014 in Atlanta, GA, .
To learn how Philips is improving the quality of healthcare through innovative solutions, inspired by human insights, visitwww.philips.com/healthcare and follow the conversation @PhilipsResp. For more information about Brightree’s updates and enhancements, visit brightree.com or follow @Brightree.
Tel: +1 724-387-4439
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Brightree is the leading provider of cloud-based software to improve clinical and business performance in the post-acute care industry. The Company serves more than 3,000 organizations in the home medical equipment (HME), home health, hospice, orthotic and prosthetic (O&P), HME pharmacy, home infusion and rehab home care segments. Brightree’s solutions follow the natural workflow of providers to automate and improve how they manage their businesses, serve patients, and protect reimbursements. The company is ranked as one of the top 100 healthcare IT companies in the U.S. on the prestigious Healthcare Informatics 100 (HCI 100) list.
Brightree is a registered trademark of Brightree LLC.
This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.